Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2

BACKGROUND: The dedifferentiated variant of chondrosarcoma is highly aggressive and carries an especially grim prognosis. While chemotherapeutics has failed to benefit patients with dedifferentiated chondrosarcoma significantly, preclinical chemosensitivity studies have been limited by a scarcity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoyang, Dean, Dylan C., Ferreira, Al, Nelson, Scott D., Hornicek, Francis J., Yu, Shengji, Duan, Zhenfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645311/
https://www.ncbi.nlm.nih.gov/pubmed/34767468
http://dx.doi.org/10.1177/10732748211045274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645311/
https://www.ncbi.nlm.nih.gov/pubmed/34767468
http://dx.doi.org/10.1177/10732748211045274

Ejemplares similares